Tools and procedures for ex vivo vein arterialization, preconditioning and tissue engineering: A step forward to translation to combat the consequences of vascular graft remodeling

Recent Patents on Cardiovascular Drug Discovery

Volumn 7, Issue 3, 2012, Pages 186-195

  Piola, Marco ^a   Soncini, Monica ^a   Prandi, Francesca ^b   Polvani, Gianluca ^c   Fiore, Gianfranco Beniamino ^a   Pesce, Maurizio ^b  

^a POLITECNICO DI MILANO   (Italy)

^b CENTRO CARDIOLOGICO MONZINO   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Bioengineering; Bioreactor; Neointima; Perfusion system; Restenosis; Vein graft

Indexed keywords

POLYMER; TISSUE SCAFFOLD;

BIOENGINEERING; BIOMECHANICS; BIOREACTOR; BLOOD VESSEL GRAFT; EX VIVO STUDY; HEART HEMODYNAMICS; HEART MUSCLE PERFUSION; HUMAN; ISCHEMIC PRECONDITIONING; MOLECULAR BIOLOGY; MOLECULAR MECHANICS; NONHUMAN; PATENT; PRIORITY JOURNAL; REVIEW;

ANIMALS; ARTERIES; BIOREACTORS; BLOOD VESSEL PROSTHESIS; HEMODYNAMICS; HUMANS; TISSUE ENGINEERING; TRANSPLANTATION CONDITIONING; VASCULAR GRAFTING; VASCULAR SURGICAL PROCEDURES; VEINS;

EID: 84870214705     PISSN: 15748901     EISSN: None     Source Type: Journal    
DOI: 10.2174/157489012803832838     Document Type: Review

References (113)

1. Parang P, Arora R. Coronary vein graft disease: Pathogenesis and prevention. Can J Cardiol 2009; 25(2): 57-62.
2. Wallitt EJ, Jevon M, Hornick PI. Therapeutics of vein graft intimal hyperplasia: 100 years on. Ann Thorac Surg 2007; 84(1): 317-23.
3. Owens CD. Adaptive changes in autogenous vein grafts for arterial reconstruction: Clinical implications. J Vasc Surg 2010; 51(3): 736-46.
4. L'Heureux N, Dusserre N, Konig G, Victor B, Keire P, Wight TN, et al. Human tissue-engineered blood vessels for adult arterial revascularization. Nat Med 2006; 12(3): 361-5.
5. Seliktar D, Nerem RM, Galis ZS. Mechanical strain-stimulated remodeling of tissue-engineered blood vessel constructs. Tissue Engineering 2003; 9(4): 657-66.
6. Niklason LE, Gao J, Abbott WM, Hirschi KK, Houser S, Marini R, et al. Functional arteries grown in vitro. Science 1999; 284(5413): 489-93.
7. Malek AM, Alper SL, Izumo S. Hemodynamic shear stress and its role in atherosclerosis. JAMA 1999; 282(21): 2035-42.
8. Bouten CV, Dankers PY, Driessen-Mol A, Pedron S, Brizard AM, Baaijens FP. Substrates for cardiovascular tissue engineering. Adv Drug Deliv Rev 2011; 63(4-5): 221-41.
9. Carrel A, Lindbergh CA. The culture of whole organs. Science 1935; 81(2112): 621-3.
10. Clerin, V., Gusic, R., Gooch, K. US20100331964A1 (2010).
11. Porter KE, Nydahl S, Dunlop P, Varty K, Thrush AJ, London NJM. The development of an in vitro flow model of human saphenous vein graft intimal hyperplasia. Cardiovasc Res 1996; 31(4): 607-14.
12. Rey J, Probst H, Mazzolai L, Bosman FTB, Pusztaszeri M, Stergiopulos N, et al. Comparative assessment of intimal hyperplasia development after 14 days in two different experimental settings: Tissue culture versus ex vivo continuous perfusion of human saphenous vein. J Surg Res 2004; 121(1): 42-9.
13. Surowiec SM, Conklin BS, Li JS, Lin PH, Weiss VJ, Lumsden AB, et al. A new perfusion culture system used to study human vein. J Surgic Res 2000; 88(1): 34-41.
14. Miyakawa AA, Dallan LAO, Lacchini S, Borin TF, Krieger JE. Human saphenous vein organ culture under controlled hemodynamic conditions. Clinics 2008; 63(5): 683-8.
15. Gusic RJ, Myung R, Petko M, Gaynor JW, Gooch KJ. Shear stress and pressure modulate saphenous vein remodeling ex vivo. J Biomechan 2005; 38(9): 1760-9.
16. Gusic RJ, Petko M, Myung R, Gaynor JW, Gooch KJ. Mechanical properties of native and ex vivo remodeled porcine saphenous veins. J Biomechanics 2005; 38(9): 1770-9.
17. Clerin V, Gusic RJ, O'Brien J, Kirshbom PM, Myung RJ, Gaynor JW, et al. Mechanical environment, donor age, and presence of endothelium interact to modulate porcine artery viability ex vivo. Ann Biomed Eng 2002; 30(9): 1117-27.
18. Clerin V, Nichol JW, Petko M, Myung RJ, Gaynor JW, Gooch KJ. Tissue engineering of arteries by directed remodeling of intact arterial segments. Tissue Eng 2003; 9(3): 461-72.
19. Saucy F, Probst H, Alonso F, Berard X, Deglise S, Dunoyer-Geindre S, et al. Ex vivo pulsatile perfusion of human saphenous veins induces intimal hyperplasia and increased levels of the plasminogen activator inhibitor 1. Eur Surg Res 2010; 45(1): 50-9.
20. Voisard, Pulsed perfusion in a venous human organ culture model with a Windkessel function (pulsed perfusion venous HOC-model), Med Sci Monit 2010; 16
21. Dummler S, Eichhorn S, Tesche C, Schreiber U, Voss B, Deutsch M-A, et al. Pulsatile ex vivo perfusion of human saphenous vein grafts under controlled pressure conditions increases MMP-2 expression. BioMed Engin OnLine 2011; 10(1): 62.
22. Wiedemann D, Kocher A, Bonaros N, Semsroth S, Laufer G, Grimm M, et al. Perivascular administration of drugs and genes as a means of reducing vein graft failure. Curr Opin Pharmacol 2012; 12(2): 203-16.
23. McDonald RA, Hata A, MacLean MR, Morrell NW, Baker AH. MicroRNA and vascular remodelling in acute vascular injury and pulmonary vascular remodelling. Cardiovasc Res 2012; 93(4): 594-604.
24. Thomas AC. Animal models for studying vein graft failure and therapeutic interventions. Curr Opin Pharmacol 2012.
25. Griese DP, Ehsan A, Melo LG, Kong D, Zhang L, Mann MJ, et al. Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy. Circulation 2003; 108(21): 2710-5.
26. Ott HC, Matthiesen TS, Goh SK, Black LD, Kren SM, Netoff TI, et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nature Med 2008; 14(2): 213-21.
27. Bader A, Macchiarini P, Moving towards in situ tracheal regeneration: the bionic tissue engineered transplantation approach. J Cell Mol Med 2010; 14(7): 1877-89.
28. Jungebluth P, Bader A, Baiguera S, Moller S, Jaus M, Lim ML, et al. The concept of in vivo airway tissue engineering. Biomaterials 2012; 33(17): 4319-26.
29. Ott HC, Clippinger B, Conrad C, Schuetz C, Pomerantseva I, Ikonomou L. et al. Regeneration and orthotopic transplantation of a bioartificial lung. Nature Med 2010; 16(8): 927-U131.
30. Uygun BE, Soto-Gutierrez A, Yagi H, Izamis ML, Guzzardi MA, Shulman C, et al. Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nature Medicine 2010; 16(7): 814-U120.
31. Barron V, Lyons E, Stenson-Cox C, McHugh PE, Pandit A. Bioreactors for cardiovascular cell and tissue growth: A review. Ann Biomed Engin 2003; 31(9): 1017-30.
32. Martin I, Wendt D, Heberer M. The role of bioreactors in tissue engineering. Trends Biotechnol 2004; 22(2): 80-6.
33. Dermenoudis S, Missirlis YF. Bioreactors in tissue engineering. Adv Engin Mat 2010; 12(11): B592-B608.
34. Banes, A.J., Wang, J., Qi, J., Kheradpir, K. Bioreactor for development of blood vessels. US20090123993A1 (2009).
35. Dunkelman, N., Peterson, A.E., Landeen, L.K., Zeltinger, J. Apparatus and method for sterilizing, seeding, culturing, storing, shipping and testing tissue, synthetic or native, vascular grafts US5792603A (1998).
36. Elizondo, D.R., Campbell, T.D., Totten, R.P. Cardiovascular biore-actor apparatus and method. US5916800A (1999).
37. Villalona GA, Udelsman B, Duncan DR, McGillicuddy E, Sawh-Martinez RF, Hibino N, et al. Cell-seeding techniques in vascular tissue engineering. Tissue Eng Part B Rev 2010; 16(3): 341-50.
38. Arrigoni C, Chitto A, Mantero S, Remuzzi A. Rotating versus perfusion bioreactor for the culture of engineered vascular constructs based on hyaluronic acid. Biotechnol Bioengin 2008; 100(5): 988-97.
39. Seifalian AM, Tiwari A, Hamilton G, Salacinski HJ. Improving the clinical patency of prosthetic vascular and coronary bypass grafts: the role of seeding and tissue engineering. Artif Organs 2002; 26(4): 307-20.
40. Konig G, McAllister TN, Dusserre N, Garrido SA, Iyican C, Marini A, et al. Mechanical properties of completely autologous human tissue engineered blood vessels compared to human saphenous vein and mammary artery. Biomaterials 2009; 30(8): 1542-50.
41. L'Heureux N, Paquet S, Labbe R, Germain L, Auger FA. A completely biological tissue-engineered human blood vessel. Faseb J 1998; 12(1): 47-56.
42. Campbell GR, Campbell JH. Development of tissue engineered vascular grafts. Curr Pharm Biotechnol 2007; 8(1): 43-50.
43. Nerem RM. Tissue engineering a blood vessel substitute: The role of biomechanics. Yonsei Med J 2000; 41(6): 735-9.
44. Sarkar S, Schmitz-Rixen T, Hamilton G, Seifalian AM. Achieving the ideal properties for vascular bypass grafts using a tissue engineered approach: A review. Medic Biologic Engin Comput 2007; 45(4): 327-36.
45. Thomas A, Advances in vascular tissue engineering. Cardiovasc Pathol 2003; 12(5): 271-6.
46. Weinberg CB, Bell E. A blood vessel model constructed from collagen and cultured vascular cells. Science 1986; 231(4736): 397-400.
47. Bell, E. Fabrication of living blood vessels and glandular tissues. US4546500 (1985).
48. L'Heureux N, Germain L, Labbe R, Auger FA. In vitro construction of a human blood vessel from cultured vascular cells: a morphologic study. J Vasc Surg 1993; 17(3): 499-509.
49. Auger, F.A., L'Heureux, N., Germain, L. Production of a contractile smooth muscle. US5618718 (1997).
50. McAllister, T.N., L'heureux, N. Tissue engineered blood vessels and apparatus for their manufacture. US20020188349A1 (2002).
51. Tranquillo, R.T., Ross, J., Reyes, M. Engineered blood vessels. US20070128171 (2007).
52. Naito Y, Shinoka T, Duncan D, Hibino N, Solomon D, Cleary M, et al. Vascular tissue engineering: Towards the next generation vascular grafts. Adv Drug Deliv Rev 2011; 63(4-5): 312-23.
53. Gong Z, Niklason LE, Blood vessels engineered from human cells. Trends Cardiovasc Med 2006; 16(5): 153-56.
54. Wang C, Cen L, Yin S, Liu Q, Liu W, Cao Y, et al. A small diameter elastic blood vessel wall prepared under pulsatile conditions from polyglycolic acid mesh and smooth muscle cells differentiated from adipose-derived stem cells. Biomaterials 2010; 31(4): 621-30.
55. Hoerstrup SP, Zund G, Sodian R, Schnell AM, Grunenfelder J, Turina MI. Tissue engineering of small caliber vascular grafts. Eur J Cardiothorac Surg 2001; 20(1): 164-9.
56. Hoerstrup SP. Functional growth in tissue-engineered living, vascular grafts: Follow-Up at 100 weeks in a large animal model. Circulation 2006; 114(suppl 1): I-159-I-166.
57. Shin'oka T, Imai Y, Ikada Y, Transplantation of a tissue-engineered pulmonary artery. N Engl J Med 2001; 344(7): 532-3.
58. Shin'oka T, Matsumura G, Hibino N, Naito Y, Watanabe M, Konuma T, et al. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg 2005; 129(6): 1330-8.
59. Quint C, Kondo Y, Manson RJ, Lawson JH, Dardik A, Niklason LE. Decellularized tissue-engineered blood vessel as an arterial conduit. P Natl Acad Sci USA 2011; 108(22): 9214-9.
60. Badylak SF, Freytes DO, Gilbert TW. Extracellular matrix as a biological scaffold material: Structure and function. Acta Biomaterialia 2009; 5(1): 1-13.
61. Fomovsky GM, Thomopoulos S, Holmes JW. Contribution of extracellular matrix to the mechanical properties of the heart. J Molecul Cellular Cardiol 2010; 48(3): 490-6.
62. Galili U. The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy. Immunol Cell Biol 2005; 83(6): 674-86.
63. Orton, E.C. Treated tissue for implantation and methods of treatment and use. US5192312 (1993).
64. Bader, A. Method for producing a bio-artificial transplant. US20120009677A1 (2012).
65. Brendel, K., Duhamel, R.C. Body implants of extracellular matrix and means and methods of making and using such implants. US4801299 (1989).
66. Crapo PM, Gilbert TW, Badylak SF. An overview of tissue and whole organ decellularization processes. Biomaterials 2011; 32(12): 3233-43.
67. Gilbert TW, Sellaro TL, Badylak SF. Decellularization of tissues and organs. Biomaterials 2006; 27(19): 3675-3683.
68. Soma, G., Kotturathu, M.C. Small diameter vascular graft from processed cadaver saphenous vein. WO2009044407A1 (2009).
69. Montoya CV, McFetridge PS. Preparation of ex vivo-based biomaterials using convective flow decellularization. Tissue Eng Part C-Me 2009; 15(2): 191-200.
70. Pellegata AF, Asnaghi MA, Zonta S, Zerbini G, Mantero S. A novel device for the automatic decellularization of biological tissues. Int J Artif Organs 2012; 35(3): 191-8.
71. Wolfinbarger, L. Bioreactor mediated recellularization of natural and tissue engineered vascular grafts. US20030219417A1 (2003).
72. Bischoff J, Kaushal S, Mayer J, Perry TE. Tissue-engineered vascular structures. US20040044403 (2004).
73. Teebken OE, Puschmann C, Breitenbach I, Rohde B, Burgwitz K, Haverich A. Preclinical development of tissue-engineered vein valves and venous substitutes using re-endothelialised human vein matrix. Eur J Vascul Endovascul Surg 2009; 37(1): 92-102.
74. Schaner PJ, Martin ND, Tulenko TN, Shapiro IM, Tarola NA, Leichter RF, et al. Decellularized vein as a potential scaffold for vascular tissue engineering. J Vascul Surg 2004; 40(1): 146-53.
75. Squillace, D. Vascular graft sterilization and decellularization. US7658706B2 (2010).
76. Dahan N, Zarbiv G, Sarig U, Karram T, Hoffman A, Machluf M. Porcine small diameter arterial extracellular matrix supports endothelium formation and media remodeling forming a promising vascular engineered biograft. Tissue Engin Part A 2012; 18(3-4): 411-22.
77. Amiel GE, Komura M, Shapira O, Yoo JJ, Yazdani S, Berry J, et al. Engineering of blood vessels from acellular collagen matrices coated with human endothelial cells. Tissue Engin 2006; 12(8): 2355-65.
78. Kaushal S, Amiel GE, Guleserian KJ, Shapira OM, Perry T, Sutherland FW, et al., Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nature Medicine 2001; 7(9): 1035-40.
79. McFetridge, P.S. Decellularized grafts from umbilical cord vessels and process for preparing and using same. US20050203636A1 (2005).
80. Lantz GC, Badylak SF, Hiles MC, Coffey AC, Geddes LA, Kokini K, et al. Small intestinal submucosa as a vascular graft: A review. J Invest Surg 1993; 6(3): 297-310.
81. Badylak S, Kokini K, Tullius B, Simmons-Byrd A, Morff R. Morphologic study of small intestinal submucosa as a body wall repair device. J Surg Res 2002; 103(2): 190-202.
82. Shi ZD, Tarbell JM. Fluid flow mechanotransduction in vascular smooth muscle cells and fibroblasts. Ann Biomedi Engin 2011; 39(6): 1608-19.
83. Dunkern TR, Paulitschke M, Meyer R, Buttemeyer R, Hetzer R, Burmester G, et al. A novel perfusion system for the endothelialization of PTFE grafts under defined flow. Eur J Vascul Endovascul Surg 1999; 18(2): 105-110.
84. Williams C, Wick TM. Perfusion bioreactor for small diameter tissue-engineered arteries. Tissue Eng 2004; 10(5-6): 930-41.
85. Tschoeke B, Flanagan TC, Cornelissen A, Koch S, Roehl A, Sriharwoko M, et al. Development of a composite degradable/nondegradable tissue-engineered vascular graft. Artificial Organs 2008; 32(10): 800-9.
86. McCulloch AD, Harris AB, Sarraf CE, Eastwood M, New multi-cue bioreactor for tissue engineering of tubular cardiovascular samples under physiological conditions. Tissue Eng 2004; 10(3-4): 565-73.
87. Bilodeau K, Couet F, Boccafoschi F, Mantovani D, Design of a perfusion bioreactor specific to the regeneration of vascular tissues under mechanical stresses. Artif Organs 2005; 29(11): 906-12.
88. Vilender, K., Nickel, T. Bioreactor with plurality of chambers for conditioning intravascular tissue engineered medical products. US7348175B2 (2008).
89. Dancu, M. Method of conditioning a hybrid synthetic tubular structure to yield a functional human hybrid coronary bypass graft US7968329B2 (2011).
90. Niklason, L.E., Gao, J., Langer, R.S. Tissue-engineered tubular construct having circumferentially oriented smooth muscle cells. US6537567B1 (2003).
91. Fan, Y., Zou, C., Li, J., Huang, X., Gong, X. Perfusion type vascular tissue bioreactor with rotary and stretching functions. US2009181448A1 (2009).
92. Sauvage, L.R., Kaplan, S. Method of making vascular prosthesis by perfusion. US4911713 (1990).
93. Boccafoschi F, Bosetti M, Mosca C, Mantovani D, Cannas M. The role of shear stress on mechanically stimulated engineered vascular substitutes: influence on mechanical and biological properties. J Tissue Engin Regener Med 2012; 6(1): 60-7.
94. Cho SW, Lim SH, Kim IK, Hong YS, Kim SS, Yoo KJ, et al. Small-diameter blood vessels engineered with bone marrow-derived cells. Ann Surg 2005; 241(3): 506-15.
95. Sodian R, Lemke T, Fritsche C, Hoerstrup SP, Fu P, Potapov EV, et al. Tissue-engineering bioreactors: A new combined cell-seeding and perfusion system for vascular tissue engineering. Tissue Eng 2002; 8(5): 863-70.
96. Iwasaki K, Kojima K, Kodama S, Paz AC, Chambers M, Umezu M, et al. Bioengineered three-layered robust and elastic artery using hemodynamically-equivalent pulsatile bioreactor. Circulation 2008; 118(14): S52-S57.
97. Thompson CA, Colon-Hernandez P, Pomerantseva I, MacNeil BD, Nasseri B, Vacanti JP, et al., A novel pulsatile, laminar flow bioreactor for the development of tissue-engineered vascular structures. Tissue Eng 2002; 8(6): 1083-8.
98. Narita Y, Hata K, Kagami H, Usui A, Ueda M, Ueda Y. Novel pulse duplicating bioreactor system for tissue-engineered vascular construct. Tissue Eng 2004; 10(7-8): 1224-33.
99. Seliktar D, Black RA, Vito RP, Nerem RM. Dynamic mechanical conditioning of collagen-gel blood vessel constructs induces remodeling in vitro. Ann Biomed Eng 2000; 28(4): 351-62.
100. Frerich, B. Perfusable bioreactor for the production and/or cultivation of a human or animal blood vessel and/or a human or animal tissue. US20110014597A1 (2011).
101. Hu Y, Zhang Z, Torsney E, Afzal AR, Davison F, Metzler B, et al. Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice. J Clin Investigat 2004; 113(9): 1258-65.
102. Torsney E, Hu Y, Xu Q. Adventitial progenitor cells contribute to arteriosclerosis. Trends Cardiovasc Med 2005; 15(2): 64-8.
103. Zhang L, Freedman NJ, Brian L, Peppel K, Graft-extrinsic cells predominate in vein graft arterialization. Arterioscler Thromb, Vasc Biol 2004; 24(3): 470-6.
104. Segal E, Shapira M, Regev A, Pe'er D, Botstein D, Koller D, et al. Module networks: identifying regulatory modules and their condition-specific regulators from gene expression data. Nature Genet 2003; 34(2): 166-76.
105. Hu Y, Mayr M, Metzler B, Erdel M, Davison F, Xu Q. Both donor and recipient origins of smooth muscle cells in vein graft atherosclerotic lesions. Circulation Res 2002; 91(7): e13-20.
106. Zhu S, Malhotra A, Zhang L, Deng S, Zhang T, Freedman NJ, et al. Human umbilical cord blood endothelial progenitor cells decrease vein graft neointimal hyperplasia in SCID mice. Atherosclerosis 2010; 212(1): 63-9.
107. Brown MA, Zhang L, Levering VW, Wu J-H, Satterwhite LL, Brian L, et al. Human umbilical cord blood-derived endothelial cells reendothelialize vein grafts and prevent thrombosis. Arterioscler Thromb, Vasc Biol 2010; 30(11): 2150-5.
108. Ergun S, Tilki D, Klein D. Vascular wall as a reservoir for different types of stem and progenitor cells. Antioxid Redox Signal 2011; 15(4): 981-95.
109. Majesky MW, Dong XR, Hoglund V, Mahoney WM, Jr., Daum G. The adventitia: A dynamic interface containing resident progenitor cells. Arterioscler Thromb, Vasc Biol 2011; 31(7): 1530-1539.
110. Torsney E, Xu Q. Resident vascular progenitor cells. J Molecul Cellular Cardiol 2011; 50(2): 304-11.
111. Campagnolo P, Cesselli D, Al Haj Zen A, Beltrami AP, Krankel N, Katare R, et al. Human adult vena saphena contains perivascular progenitor cells endowed with clonogenic and proangiogenic potential. Circulation 2010; 121(15): 1735-45.
112. Berger SL. The complex language of chromatin regulation during transcription. Nature 2007; 447(7143): 407-12.
113. Kouzarides T. Chromatin modifications and their function. Cell 2007; 128(4): 693-705.